Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

NCT00439244 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

412

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Zoledronic acid
DRUG: Placebo
DRUG: Teriparatide

Sponsor

Novartis